NZ186465A - A process for producing dl-5-methyltetrahydrofolic acid or its salts and stable pharmaceutical compositions - Google Patents
A process for producing dl-5-methyltetrahydrofolic acid or its salts and stable pharmaceutical compositionsInfo
- Publication number
- NZ186465A NZ186465A NZ186465A NZ18646578A NZ186465A NZ 186465 A NZ186465 A NZ 186465A NZ 186465 A NZ186465 A NZ 186465A NZ 18646578 A NZ18646578 A NZ 18646578A NZ 186465 A NZ186465 A NZ 186465A
- Authority
- NZ
- New Zealand
- Prior art keywords
- salts
- producing
- pharmaceutical compositions
- stable pharmaceutical
- methyltetrahydrofolic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
- C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7290/77A GB1572137A (en) | 1977-02-22 | 1977-02-22 | Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ186465A true NZ186465A (en) | 1980-10-08 |
Family
ID=9830275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ186465A NZ186465A (en) | 1977-02-22 | 1978-02-13 | A process for producing dl-5-methyltetrahydrofolic acid or its salts and stable pharmaceutical compositions |
Country Status (32)
Country | Link |
---|---|
JP (1) | JPS5831353B2 (en) |
AR (1) | AR215162A1 (en) |
AT (1) | AT380020B (en) |
AU (1) | AU520715B2 (en) |
BE (1) | BE863808A (en) |
CA (1) | CA1093554A (en) |
CH (1) | CH635344A5 (en) |
CZ (1) | CZ279815B6 (en) |
DD (1) | DD134099A5 (en) |
DE (1) | DE2807393A1 (en) |
DK (1) | DK144944C (en) |
EG (1) | EG13399A (en) |
ES (1) | ES467153A1 (en) |
FI (1) | FI67082C (en) |
FR (2) | FR2381047A1 (en) |
GB (1) | GB1572137A (en) |
GR (1) | GR71704B (en) |
HU (1) | HU179422B (en) |
IE (1) | IE46402B1 (en) |
IL (1) | IL54052A (en) |
IN (1) | IN149574B (en) |
LU (1) | LU79067A1 (en) |
MX (1) | MX5288E (en) |
NL (1) | NL190285C (en) |
NO (1) | NO147793C (en) |
NZ (1) | NZ186465A (en) |
PL (1) | PL118654B1 (en) |
PT (1) | PT67656B (en) |
SE (1) | SE437028B (en) |
SU (1) | SU747427A3 (en) |
YU (1) | YU40505B (en) |
ZA (1) | ZA78837B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5838285A (en) * | 1981-08-25 | 1983-03-05 | Kanegafuchi Chem Ind Co Ltd | Preparation of 5-methyl-(6rs)-5,6,7,8-tetrahydro-l-folic acid magnesium salt or its free acid |
GB8621268D0 (en) * | 1986-09-03 | 1986-10-08 | Univ Strathclyde | Separation of substances |
IT1229517B (en) * | 1989-01-31 | 1991-09-03 | Bioresearch Spa | USE OF 5-METHYLTETRAHYDROPHOLIC ACID, OF 5 FORMYLTHETRAHYDROPHOLIC ACID, AND OF THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE SUITABLE FOR BEING EMPLOYED IN THE TREATMENT OF DISORDERS IN THE TREATMENT OF DISORDERS. |
IT1229203B (en) * | 1989-03-22 | 1991-07-25 | Bioresearch Spa | USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS. |
NL8901432A (en) * | 1989-06-06 | 1991-01-02 | Pharmachemie Bv | STABLE AQUEOUS FOLINATE SOLUTION AT REFRIGERATOR TEMPERATURE, AND METHOD FOR PREPARING THAT. |
CH680731A5 (en) * | 1990-04-12 | 1992-10-30 | Sapec Fine Chemicals | |
US5217974A (en) * | 1991-03-29 | 1993-06-08 | Eli Lilly And Company | Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity |
CH683261A5 (en) * | 1991-10-10 | 1994-02-15 | Applied Pharma Res | A process for the preparation of Methyltetrahydrofolic in the form (6 (R, S) (-)) N-5 and separation of the active diastereoisomer (6 (S) (-)) N-5) in the form of salts. |
CH682665A5 (en) * | 1991-10-29 | 1993-10-29 | Sapec Fine Chemicals | Process for the purification of crude alkaline earth metal salts from N (5) -methyl-5,6,7,8-tetrahydrofolic acid. |
US6162914A (en) * | 1998-04-24 | 2000-12-19 | Cerbios-Pharma S.A. | Process for the reduction of pterins |
CH693905A5 (en) * | 1999-04-15 | 2004-04-15 | Eprova Ag | Stable crystalline salts of 5-methyl tetrahydrofolic acid. |
CH698729B1 (en) * | 2007-05-30 | 2009-10-15 | Cerbios Pharma Sa | Stable crystalline (6S) -N (5) -methyl-5, 6,7,8-tetrahydrofolic acid. |
CN103214487A (en) * | 2013-04-12 | 2013-07-24 | 张家港威胜生物医药有限公司 | Synthesis of important medical chemical raw material (6S)-5-methyl tetrahydrofolate |
WO2015193778A1 (en) | 2014-06-16 | 2015-12-23 | Mylan Laboratories Ltd. | Crystalline form of levomefolate calcium |
US20210324176A1 (en) | 2018-08-28 | 2021-10-21 | Pmc Organometallix, Inc. | Low free 2-mercaptoethanol ester and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL80276C (en) * | ||||
GB1293541A (en) * | 1969-03-18 | 1972-10-18 | John Alexander Blair | Folic acid derivatives |
US3856959A (en) * | 1972-07-24 | 1974-12-24 | Department Of Health Education | Inhibition of leukemia utilizing 5-methyltetrahydrohomofolate |
US4148999A (en) * | 1977-08-22 | 1979-04-10 | The Government Of The United States Of America | Preparation and purification of citrovorum factor |
CH649550A5 (en) * | 1984-02-09 | 1985-05-31 | Eprova Ag | Process for the preparation of alkaline earth metal salts of 5-methyltetrahydrofolic acid |
-
1977
- 1977-02-22 GB GB7290/77A patent/GB1572137A/en not_active Expired
-
1978
- 1978-02-09 AT AT0090378A patent/AT380020B/en not_active IP Right Cessation
- 1978-02-09 CA CA296,754A patent/CA1093554A/en not_active Expired
- 1978-02-09 BE BE185038A patent/BE863808A/en not_active IP Right Cessation
- 1978-02-09 IE IE285/78A patent/IE46402B1/en not_active IP Right Cessation
- 1978-02-13 ZA ZA00780837A patent/ZA78837B/en unknown
- 1978-02-13 NZ NZ186465A patent/NZ186465A/en unknown
- 1978-02-15 LU LU79067A patent/LU79067A1/en unknown
- 1978-02-15 IN IN174/CAL/78A patent/IN149574B/en unknown
- 1978-02-15 PT PT67656A patent/PT67656B/en unknown
- 1978-02-15 IL IL54052A patent/IL54052A/en unknown
- 1978-02-16 NL NLAANVRAGE7801775,A patent/NL190285C/en not_active IP Right Cessation
- 1978-02-18 PL PL1978204747A patent/PL118654B1/en unknown
- 1978-02-20 AU AU33430/78A patent/AU520715B2/en not_active Expired
- 1978-02-20 DD DD78203761A patent/DD134099A5/en unknown
- 1978-02-20 GR GR55500A patent/GR71704B/el unknown
- 1978-02-20 YU YU379/78A patent/YU40505B/en unknown
- 1978-02-21 NO NO780594A patent/NO147793C/en unknown
- 1978-02-21 EG EG103/78A patent/EG13399A/en active
- 1978-02-21 FI FI780565A patent/FI67082C/en not_active IP Right Cessation
- 1978-02-21 SE SE7801973A patent/SE437028B/en not_active IP Right Cessation
- 1978-02-21 DK DK76578A patent/DK144944C/en not_active IP Right Cessation
- 1978-02-21 DE DE19782807393 patent/DE2807393A1/en active Granted
- 1978-02-21 FR FR7804847A patent/FR2381047A1/en active Granted
- 1978-02-21 MX MX786871U patent/MX5288E/en unknown
- 1978-02-21 SU SU782588551A patent/SU747427A3/en active
- 1978-02-21 ES ES467153A patent/ES467153A1/en not_active Expired
- 1978-02-22 HU HU78BI562A patent/HU179422B/en unknown
- 1978-02-22 CH CH193678A patent/CH635344A5/en not_active IP Right Cessation
- 1978-02-22 CZ CS781129A patent/CZ279815B6/en unknown
- 1978-02-22 JP JP53018637A patent/JPS5831353B2/en not_active Expired
- 1978-02-22 AR AR271183A patent/AR215162A1/en active
- 1978-07-13 FR FR7820936A patent/FR2385397A1/en active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT68600A (en) | Process for the preparation of a pharmaceutical compositioof enhanced stability | |
DE2860896D1 (en) | N-substituted 9,10-dihydrolysergic acid esters and a method for their preparation | |
IL52023A (en) | Process for the preparation of di-n-propyl-acetic acid and salts thereof | |
NZ186465A (en) | A process for producing dl-5-methyltetrahydrofolic acid or its salts and stable pharmaceutical compositions | |
ATA387777A (en) | Process for the preparation of the novel 17,18- dehydroapovincaminol and its acid addition salts | |
PT68447A (en) | 2-bromoergosine and its acid addition salts a process for the preparation thereof and their use in medicines | |
GB2005687B (en) | Pepides acid addition salts thereof and process for prperation thereof | |
HU177923B (en) | Process for preparing acid addition salts of 7,8-dihydro-14-hydroxy-normorfinone | |
JPS5390297A (en) | Novel imidazoquinoline salts thereof process for preparing same and pharmaceutical composition | |
PH15510A (en) | Phosphonous acid derivatives and process for their preparation | |
ZA785628B (en) | New imidazobenzoxazines and their salts,process for their preparation and pharmaceutical compositions | |
HU178713B (en) | Process for producing raceme and optically active apovincaminic acid and salts | |
PT68946A (en) | Process for the preparation of salicylic acid and derivatives thereof | |
IL55152A0 (en) | 7-acylamido-3-cephem-4-carboxylic acids and esters and salts thereof,their preparation and pharmaceutical compositions containing them | |
DE2860702D1 (en) | 7-amino-5h-benzocycloheptene derivatives and their salts, a process for their preparation, their use as medicines and pharmaceutical compositions containing them | |
DE2860815D1 (en) | Derivatives of monic acid a, and process for their preparation | |
DE2860609D1 (en) | Bis-azido-phthalic acid derivatives and process for their preparation | |
HU173380B (en) | Process for producing new pyridyl-piperazine derivatives and acid additional salts thereof | |
IL55006A (en) | Oxaminic acids and salts and esters thereof,their production and pharmaceutical compositions containing them | |
GB2009177B (en) | Amino-and guanidino -1,2,3,4 - tetrahydro -unaphtoic acid esters process for their preparation and pharmaceutical compositions containing them | |
GR63662B (en) | Piperazinecarbodithioic acid derivatives process for their preparation and pharmaceutical compositions containing them | |
HU179217B (en) | Process for preparing a pharmaceutical composition for sensibilisation | |
ZA802635B (en) | Substituted pyrrolidinyl-benzoic acid derivatives and a process for their manufacture | |
IL54614A (en) | Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them | |
IL55229A (en) | 1-substituted-3-pyrrolidinylaminocarbonyl oxanilic acid,esters and metal salts,their preparation and pharmaceutical compositions containing them |